Gladstone Institutes Launches Redesigned Website, Bringing Cutting-Edge Biomedical Research Into Focus
Discover disease research, explore the latest scientific news, and connect with experts through Gladstone’s enriched digital platform.
Gladstone Institutes today announced the launch of its newly redesigned website, gladstone.org, offering a modernized, accessible platform that brings its biomedical research closer to the public, scientific community, and key partners.
Developed in partnership with KNI (Kurt Noble, Inc.), an award-winning full-service digital and design agency based in San Francisco, the redesigned site reflects Gladstone’s commitment to driving innovation and leveraging science to overcome disease. The new digital experience features a clean, intuitive architecture and interactive elements that streamline how visitors explore Gladstone’s transformative discoveries.
A central highlight of the new website is a clear emphasis on Gladstone’s core disease and technology areas, making complex scientific concepts and multi-disciplinary research more inviting for patients, the public, and the larger scientific community. The site also introduces a revamped News and Insights page—a central hub for the latest developments, breakthroughs, and stories emerging from Gladstone—and an enhanced search function to ensure seamless discovery of researchers, publications, and scientific topics.
“Our goal with this redesign was to create an online experience as innovative and forward-thinking as the research taking place inside our labs every day,” says Anna-Marie Rooney, vice president of communications at Gladstone. “By reorganizing our site around disease areas and implementing enhanced design and search elements, we’re opening our doors wider to the public, making our science accessible and engaging for everyone who visits.”
Gladstone is dedicated to disease-focused discovery research, with more than 600 biologists, chemists, engineers, and data scientists who bring a deep mechanistic understanding of how the human body works and what goes wrong in disease. Our expertise in artificial intelligence and data science is integrated into all research areas at Gladstone—accelerating discoveries across cardiology, neurology, infectious diseases, and immunology for cancer and autoimmune diseases.
The new website reflects this, highlighting not only key disease areas of focus, but also the tools and technologies that enable breakthroughs and speed their translation into new therapies.
“As users explore our new website, they will also uncover Gladstone’s updated and refined brand,” Rooney says. “Drawing inspiration from the complexity of human biology and the hard work of our scientists, our brand showcases unique microscopy images, intricate textures and shapes, and memorable photographs that will take our audience on a tour of our research and our culture.”
To explore the new platform and learn more about Gladstone’s work to overcome disease, visit gladstone.org.
For Media
About Gladstone
Gladstone Institutes is an independent, nonprofit biomedical research organization dedicated to overcoming disease through innovative science. Located in San Francisco, Gladstone focuses its research on cardiovascular diseases, neurological conditions, immunotherapy for cancer and autoimmune diseases, and infectious diseases. Using AI and new technologies, Gladstone is steering to a new world of cures and prevention for currently intractable diseases.
Up Next
Gladstone’s Seth Shipman Named Fellow of the California Academy of Sciences
Shipman is recognized for pioneering molecular technologies that record cellular activity, expand genome editing, and target antibiotic-resistant superbugs.
Novel Biosensor Uses DNA ‘Barcodes’ to Uncover Disease Signals in Cells
Inspired by bacterial biology, the Gladstone-developed “Detectron” opens up new possibilities for disease research and potentially treatments.
Meet Gladstone: Ayush Midha
Ayush Midha, a graduate student in the Jain Lab, studies how the body's metabolism adapts to low oxygen—work that's uncovered backup energy pathways, potential fertility treatments, and a link between oxygen levels and tumor growth.
How a Single Viral Protein Hijacks Immune Cells to Supercharge COVID-19 Infection
A new discovery reveals how a SARS-CoV-2 protein reprograms immune cells to accelerate viral spread—and points to a new strategy for therapeutic intervention.
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now